Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.54 -0.05 (-1.93%)
As of: Oct 2, 2026 · 3:07 PM EDT

Rocket Pharmaceuticals (RCKT) Preferred Stock Liabilities (2014 - 2015)

Updated

Rocket Pharmaceuticals (RCKT) posted Preferred Stock Liabilities of $46.38 million for Q3 2015, unchanged from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Preferred Stock Liabilities (2014 - 2015) Analysis & Trends

At the end of FY2014, Rocket Pharmaceuticals' Preferred Stock Liabilities came in at $46.8 million.

  • Quarterly Preferred Stock Liabilities has run from a low of $46.38 million in Q1 2015 to a high of $46.8 million in Q4 2014 over five years.
  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $46.38 million (Q2 2015), $46.38 million (Q1 2015) and $46.8 million (Q4 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rocket Pharmaceuticals 288.09 Mn 288.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 46.38 Mn
Jun 30, 2015 46.38 Mn
Mar 31, 2015 46.38 Mn
Dec 31, 2014 46.80 Mn
API Access

Rocket Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=RCKT&period=max&api_key=YOUR_API_KEY